Opsona Therapeutics Ltd
Opsona is a drug development company that focuses on regulation of the human immune system. The company is identifying and developing new drugs and vaccines to treat and prevent autoimmune / inflammatory diseases as well as carriers & infectious diseases.
Opsona was founded in March 2004, and is a campus company based at Trinity College Dublin. Opsona’s academic founders are three of Ireland’s leading immunologists, and are considered world-leaders in their areas of expertise.
We are validating and developing a number of exciting drug candidates and strategies which function by modulating the Innate Immune System. More details on our products will be made available soon.
Opsona’s investors are international and life-science focused: Inventages Venture Capital (Bahamas), Seroba Bioventures (Ireland), Genentech (USA), Enterprise Ireland (Ireland)
